The PC3 cells could be utilized to study AR-independent disease and the ENZ resistance model since cancer cells can develop alternative mechanisms, such as GR overexpression, to effectively develop therapeutic strategies to circumvent the effects of AR blockage50. The gene discussed is AR; the disease is cancer.